Pliant Therapeutics announced that the latest data from the Phase 1 clinical trial of its investigational drug Pln-101095 for patients with immune checkpoint inhibitor (ICI)-refractory solid tumors will be presented in a special report at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Pliant Therapeutics announced that the latest data from the Phase 1 clinical trial of its investigational drug Pln-101095 for patients with immune checkpoint inhibitor (ICI)-refractory solid tumors will be presented in a special report at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This groundbreaking study aims to evaluate the safety and preliminary efficacy of Pln-101095 in patients with advanced solid tumors, providing new potential directions for tumor immunotherapy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$75,709.16
-2.41%
Ethereum
ETH
$2,349.15
-3.53%
Tether USDt
USDT
$1
-0.02%
XRP
XRP
$1.43
-4.22%
BNB
BNB
$630.32
-1.85%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$86.12
-3.59%
TRON
TRX
$0.3297
+0.78%
Dogecoin
DOGE
$0.09475
-5.41%
Hyperliquid
HYPE
$43.97
-1.06%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now